A Study With Arctic Root Compared With the Extract When Combined With Schizandra and Russian Root (Adapt 232), Standardized Ginseng Extract and Placebo Regarding Impact on the Level of Energy, Ability to Work Under Stress, Quality of Life and Wellbeing, in Middleaged Women Who Are Still Employed

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2010-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is clinical trial to document the efficacy of a proprietary standardized extract of Arctic root in comparison to a standardized commercial extract of ginseng and placebo from an every day consumer perspective to ameliorate mild depression, reduce stress and improve quality of life. A newly developed adaptogenic formulation, Adapt 232, was included into the study in order to evaluate its effect in comparison to the others.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acute Effects of a Botanical Extract and Its Main Volatile Compound on Stress Response in Healthy Adults

NCT04523870

Healthy

COMPLETED NA

Study to Assess the Effect of Multi-herb Formulae and an Ashwagandha Root Formula on the Modulation of the Stress and Related Symptoms

NCT05602389

Stress

COMPLETED NA

ACUTE AND CHRONIC EFFECTS OF A BOTANICAL EXTRACT ON ANXIETY, PERCEIVED STRESS, MOOD AND CORTISOL IN HEALTHY ADULTS

NCT03639831

Mood Disorders

COMPLETED NA

Effects of Ashwagandha Extract on Stress Levels

NCT06793891

Stress

RECRUITING NA

Ginseng HRG80 in Stress and Fatigue

NCT03947554

Psychological Stress

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adapt 232

Group Type EXPERIMENTAL

Rhodiola rosea, L., Eleutherococcus senticosus, Schisandra chinensis

Intervention Type DRUG

3 capsules twice a day

Arctic root group

Group Type EXPERIMENTAL

Rhodiola rosea, L

Intervention Type DRUG

3 Capsules twice a day

Ginseng group

Group Type ACTIVE_COMPARATOR

Panax ginseng

Intervention Type DRUG

3 capsules twice a day

Placebo group

Group Type PLACEBO_COMPARATOR

Placebo - dark brown sugar

Intervention Type DRUG

3 capsules twice a day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rhodiola rosea, L

3 Capsules twice a day

Intervention Type DRUG

Rhodiola rosea, L., Eleutherococcus senticosus, Schisandra chinensis

3 capsules twice a day

Intervention Type DRUG

Panax ginseng

3 capsules twice a day

Intervention Type DRUG

Placebo - dark brown sugar

3 capsules twice a day

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy females, over 40 years of age, who have stated that they for a longer period of time have felt stressed due to demanding daily activities at work and/or at home.

Exclusion Criteria

* suffering from any known medical disease, e.g. cardiovascular, joint, and liver or kidney diseases, cancer, or psychiatric disease.
* with a psychiatric diagnose, using narcotics or suffering from HIV.
* with known allergy to any of the study medications.
* misusing euphorizing or pain killing drugs
* having used any adaptogenic product the last 2 months.
* having used cortisol or any other corticosteroid products the last 6 months
* being pregnant or breast-feeding
* which at the first interview are judged to be not cooperative or not to be able to finalize the study

Minimum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No